Fluxion New Products Posted to GenomeWeb: Horizon Discovery, Fluxion Biosciences, Caris Life Sciences, More Fluxion Bio Wins $280K NIH Grant to Develop NIPT Assay The firm will validate a model system for test development, integrate key test components, and compare Spotlight to other NIPT assays. Fluxion Biosciences, Cleveland Clinic Validating Erase-Seq Mutation Variant Caller Platform Premium The firm is partnering with the Cleveland Clinic to validate its mutation variant caller platform in hepatocellular cancer cell-free tumor DNA samples. Fluxion, Harvard Bioscience Ink Distribution Deal Harvard Bioscience will offer Fluxion's BioFlux and IonFlux cellular analysis platforms to its North American customers. Fluxion Bioscience, UTHealth Collaborate on Liquid Biopsy Development Both institutions aim to develop novel liquid biopsy approaches that would improve physicians' ability to diagnose, monitor, and treat cancer patients. Jun 2, 2015 Swift Bio, Fluxion Develop Liquid Biopsy Workflow Jun 18, 2014 Fluxion, Stanford Team on CTC Test Development Jul 30, 2013 Bulldog Bio, Fluxion Reach Distribution Deal for Flow Cell Instruments May 28, 2013 Molecular Devices Inks Distribution Deal with Fluxion Biosciences Oct 15, 2012 Fluxion Registers Facility with FDA for Manufacture of IsoFlux System Oct 12, 2012 Cellectricon, Fluxion Settle Microfluidic Cellular Analysis IP Dispute Jun 28, 2012 Fluxion, Stanford Co-Developing Tests for CTCs Jun 5, 2012 Fluxion, Rubicon Team on CTC Applications Jun 1, 2012 In Brief This Week: Transgenomic; Fluxion Biosciences; Silicon Biosystems; DNA Genotek; Annai Systems Feb 3, 2010 Fluxion Denies IP Infringement Claims Made by Cellectricon Dec 4, 2009 Fluxion Biosciences Expands into Asian Market Aug 20, 2009 Fluxion Nets $1.8M NIH Grant Jul 23, 2009 Fluxion Nets $200K SBIR Grant Apr 22, 2009 Fluxion Taps EuroClone as Distributor Feb 27, 2009 New Products: Feb 27, 2009 Premium Breaking News Singular Genomics Systems Reports No Revenues, Increased Net Loss for Q2 Burning Rock Biotech, Impact Therapeutics Partner on CDx for PARP Inhibitor Senaparib Gene Editing Analysis Firm SeQure Dx Closes $17.5M Series A Funding Round Resolve Biosciences, Zeiss Partner to Enhance Spatial Biology Imaging Tech EliTechGroup Obtains CE Mark for Saliva Use With SARS-CoV-2 Test Waters Q2 Revenues Up 31 Percent The Scan And Back The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database. Lacks Family Hires Attorney A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports. For the Unknown The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona. PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.